Status:
COMPLETED
Therapeutic Exercise to Treat Neuropathic Pain
Lead Sponsor:
Universidad de Zaragoza
Collaborating Sponsors:
fundación española para el estudio y tratamiento de la Enfermedad de Gaucher y otras lisosomales
Fundación San Valero
Conditions:
Gaucher Disease
Fabry Disease
Eligibility:
All Genders
16-65 years
Phase:
NA
Brief Summary
A quasi-experimental, prospective clinical trial with pre and post intervention measurements, whose porpuose is assess the efficacy of a therapeutic exercise protocol to treat neuropathic pain in Fabr...
Detailed Description
There take part in this study women or men aged between 18 and 65 years, with a diagnosys by a physician specializing in Fabry disease with FabryScan. Patients must present a stable evolution, with a ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Female or male patients between 18 years and 65 years.
- Patients diagnosed by a doctor specializing in Fabry disease with FabryScan.
- Fabry's disease must have a stable evolution, with a disease severity scoring system (DS3) that must be less than 8 points per year in the last 2-3 years.
- Presence of neuropathic pain with a score greater than or equal to 4 in the "Douleur neuropathique (DN4)" questionnaire.
- Exclusion criteria:
- Patients with an acute cardiovascular disease or with a heart or kidney transplant.
- Subjects with acute orthopedic problems that limit their participation in the study.
- Subjects with cognitive impairments that prevent them from filling in the questionnaires or understanding the exercises to be performed.
Exclusion
Key Trial Info
Start Date :
May 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 14 2020
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04050137
Start Date
May 2 2019
End Date
December 14 2020
Last Update
December 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FEETEG
Zaragoza, Spain